Medical & Biological Laboratories to Sell In Vitro Diagnostics Products for Immunodiagnostic Systems.Tokyo, Japan, June 1, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Medical & Biological Laboratories (MBL MBL Mobile MBL Marine Biological Laboratory MBL Macquarie Bank Limited MBL Mannose-Binding Lectin MBL Marine Boundary Layer MBL Member Business Lending (credit unions) MBL Movimiento Bolivia Libre ) announced on May 30 that it entered into a sales agreement with Immunodiagnostic immunodiagnostic pertaining to diagnosis by immune reactions. Systems (IDS) of the UK as of March 31. Under the agreement, MBL receives exclusive rights to market 23 types of in vitro diagnostics In vitro diagnostic (IVD) tests are medical tests conducted in a test tube, or more generally in a controlled environment outside a living organism. In vitro means in glass in Latin. products offered by IDS in Japan, including reagents for proteins and bone metabolism markers and an osteoporosis diagnostic product. As an initial step, MBL will begin marketing reagents for research on July 1. Further, MBL plans to file an application for manufacturing approval of two in vitro diagnostic products within the year. It aims to obtain approval for the two products in early 2007 and generate sales of 50 million yen (US$450,000) in 2008 and 200 million yen (US$1.8 mil) in 2010. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion